<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0465">
 <element-citation publication-type="journal" id="sbref0465">
  <person-group person-group-type="author">
   <name>
    <surname>Fätkenheuer</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Hoffmann</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Slim</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Rouzier</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Keung</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Treitel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sansone-Parsons</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kasserra</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>O’Mara</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Schürmann</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Short-term administration of the CCR5 antagonist vicriviroc to patients with HIV and HCV coinfection is safe and tolerable</article-title>
  <source>J. Acquir. Immune Defic. Syndr.</source>
  <volume>53</volume>
  <year>2010</year>
  <fpage>78</fpage>
  <lpage>85</lpage>
  <pub-id pub-id-type="doi">10.1097/QAI.0b013e3181bb28dc</pub-id>
  <pub-id pub-id-type="pmid">19838130</pub-id>
 </element-citation>
</ref>
